We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A novel protein tyrosine phosphatase gene is mutated in progressive myoclonus epilepsy of the Lafora type (EPM2).
- Authors
Serratosa, J M; Gómez-Garre, P; Gallardo, M E; Anta, B; de Bernabé, D B; Lindhout, D; Augustijn, P B; Tassinari, C A; Malafosse, R M; Topcu, M; Grid, D; Dravet, C; Berkovic, S F; de Córdoba, S R
- Abstract
Progressive myoclonus epilepsy of the Lafora type or Lafora disease (EPM2; McKusick no. 254780) is an autosomal recessive disorder characterized by epilepsy, myoclonus, progressive neurological deterioration and glycogen-like intracellular inclusion bodies (Lafora bodies). A gene for EPM2 previously has been mapped to chromosome 6q23-q25 using linkage analysis and homozygosity mapping. Here we report the positional cloning of the 6q EPM2 gene. A microdeletion within the EPM2 critical region, present inhomozygosis in an affected individual, was found to disrupt a novel gene encoding a putative protein tyrosine phosphatase (PTPase). The gene, denoted EPM2, presents alternative splicing in the 5' and 3' end regions. Mutational analysis revealed that EPM2 patients are homozygous for loss-of-function mutations in EPM2. These findings suggest that Lafora disease results from the mutational inactivation of a PTPase activity that may be important in the control of glycogen metabolism.
- Publication
Human molecular genetics, 1999, Vol 8, Issue 2, p345
- ISSN
0964-6906
- Publication type
Journal Article
- DOI
10.1093/hmg/8.2.345